Loss of Junctional Adhesion Molecule A Promotes Severe Steatohepatitis in Mice on a Diet High in Saturated Fat, Fructose, and Cholesterol.

BACKGROUND & AIMS There is evidence from clinical studies that compromised intestinal epithelial permeability contributes to the development of nonalcoholic steatohepatitis (NASH), but the exact mechanisms are not clear. Mice with disruption of the gene (F11r) encoding junctional adhesion molecule A (JAM-A) have defects in intestinal epithelial permeability. We used these mice to study how disruption of the intestinal epithelial barrier contributes to NASH. METHODS Male C57BL/6 (control) or F11r(-/-) mice were fed a normal diet or a diet high in saturated fat, fructose, and cholesterol (HFCD) for 8 weeks. Liver and intestinal tissues were collected and analyzed by histology, quantitative reverse-transcription polymerase chain reaction, and flow cytometry. Intestinal epithelial permeability was assessed in mice by measuring permeability to fluorescently labeled dextran. The intestinal microbiota were analyzed using 16S ribosomal RNA sequencing. We also analyzed biopsy specimens from proximal colons of 30 patients with nonalcoholic fatty liver disease (NAFLD) and 19 subjects without NAFLD (controls) undergoing surveillance colonoscopy. RESULTS F11r(-/-) mice fed a HFCD, but not a normal diet, developed histologic and pathologic features of severe NASH including steatosis, lobular inflammation, hepatocellular ballooning, and fibrosis, whereas control mice fed a HFCD developed only modest steatosis. Interestingly, there were no differences in body weight, ratio of liver weight:body weight, or glucose homeostasis between control and F11r(-/-) mice fed a HFCD. In these mice, liver injury was associated with significant increases in mucosal inflammation, tight junction disruption, and intestinal epithelial permeability to bacterial endotoxins, compared with control mice or F11r(-/-) mice fed a normal diet. The HFCD led to a significant increase in inflammatory microbial taxa in F11r(-/-) mice, compared with control mice. Administration of oral antibiotics or sequestration of bacterial endotoxins with sevelamer hydrochloride reduced mucosal inflammation and restored normal liver histology in F11r(-/-) mice fed a HFCD. Protein and transcript levels of JAM-A were significantly lower in the intestinal mucosa of patients with NAFLD than without NAFLD; decreased expression of JAM-A correlated with increased mucosal inflammation. CONCLUSIONS Mice with defects in intestinal epithelial permeability develop more severe steatohepatitis after a HFCD than control mice, and colon tissues from patients with NAFLD have lower levels of JAM-A and higher levels of inflammation than subjects without NAFLD. These findings indicate that intestinal epithelial barrier function and microbial dysbiosis contribute to the development of NASH. Restoration of intestinal barrier integrity and manipulation of gut microbiota might be developed as therapeutic strategies for patients with NASH.

[1]  A. Diehl,et al.  Mouse Models of Diet-Induced Nonalcoholic Steatohepatitis Reproduce the Heterogeneity of the Human Disease , 2015, PloS one.

[2]  F. Anania,et al.  Saturated fat and cholesterol are critical to inducing murine metabolic syndrome with robust nonalcoholic steatohepatitis. , 2015, The Journal of nutritional biochemistry.

[3]  M. Dave,et al.  Hepatic Injury in Nonalcoholic Steatohepatitis Contributes to Altered Intestinal Permeability , 2015, Cellular and molecular gastroenterology and hepatology.

[4]  S. Dowd,et al.  Functional divergence in gastrointestinal microbiota in physically-separated genetically identical mice , 2014, Scientific Reports.

[5]  C. Perry,et al.  Sevelamer Carbonate: A Review in Hyperphosphataemia in Adults with Chronic Kidney Disease , 2014, Drugs.

[6]  David Artis,et al.  Intestinal epithelial cells: regulators of barrier function and immune homeostasis , 2014, Nature Reviews Immunology.

[7]  C. Scavone,et al.  Clinical Efficacy, Safety and Anti-Inflammatory Activity of Two Sevelamer Tablet Forms in Patients on Low-Flux Hemodialysis , 2014, International journal of immunopathology and pharmacology.

[8]  A. Wree,et al.  From NAFLD to NASH to cirrhosis—new insights into disease mechanisms , 2013, Nature Reviews Gastroenterology &Hepatology.

[9]  Lucie Geurts,et al.  Cross-talk between Akkermansia muciniphila and intestinal epithelium controls diet-induced obesity , 2013, Proceedings of the National Academy of Sciences.

[10]  S. Sarker Faculty Opinions recommendation of Dietary-fat-induced taurocholic acid promotes pathobiont expansion and colitis in Il10-/- mice. , 2013 .

[11]  Lixin Zhu,et al.  Characterization of gut microbiomes in nonalcoholic steatohepatitis (NASH) patients: A connection between endogenous alcohol and NASH , 2013, Hepatology.

[12]  T. Denning,et al.  Compromised intestinal epithelial barrier induces adaptive immune compensation that protects from colitis. , 2012, Immunity.

[13]  J. Clemente,et al.  Transient inability to manage proteobacteria promotes chronic gut inflammation in TLR5-deficient mice. , 2012, Cell host & microbe.

[14]  J. George,et al.  Management of nonalcoholic steatohepatitis: an evidence-based approach. , 2012, Clinics in liver disease.

[15]  Y. Sanz,et al.  Bacteroides uniformis CECT 7771 Ameliorates Metabolic and Immunological Dysfunction in Mice with High-Fat-Diet Induced Obesity , 2012, PloS one.

[16]  H. Kirikoshi,et al.  Hyperresponsivity to low-dose endotoxin during progression to nonalcoholic steatohepatitis is regulated by leptin-mediated signaling. , 2012, Cell metabolism.

[17]  Kevin W Eliceiri,et al.  NIH Image to ImageJ: 25 years of image analysis , 2012, Nature Methods.

[18]  Richard Hansen,et al.  IBD—what role do Proteobacteria play? , 2012, Nature Reviews Gastroenterology &Hepatology.

[19]  Yunwei Wang,et al.  Dietary fat-induced taurocholic acid production promotes pathobiont and colitis in IL-10−/− mice , 2012, Nature.

[20]  William A. Walters,et al.  Ultra-high-throughput microbial community analysis on the Illumina HiSeq and MiSeq platforms , 2012, The ISME Journal.

[21]  G. Gores,et al.  Fast food diet mouse: novel small animal model of NASH with ballooning, progressive fibrosis, and high physiological fidelity to the human condition. , 2011, American journal of physiology. Gastrointestinal and liver physiology.

[22]  P. Scully,et al.  Small Intestinal Bacterial Overgrowth in Nonalcoholic Steatohepatitis: Association with Toll-Like Receptor 4 Expression and Plasma Levels of Interleukin 8 , 2011, Digestive Diseases and Sciences.

[23]  S. Friedman,et al.  Mechanisms of hepatic fibrogenesis. , 2011, Best practice & research. Clinical gastroenterology.

[24]  Rick L. Stevens,et al.  The Earth Microbiome Project: Meeting report of the “1st EMP meeting on sample selection and acquisition” at Argonne National Laboratory October 6th 2010. , 2010, Standards in genomic sciences.

[25]  B. Neuschwander‐Tetri Hepatic lipotoxicity and the pathogenesis of nonalcoholic steatohepatitis: The central role of nontriglyceride fatty acid metabolites , 2010, Hepatology.

[26]  William A. Walters,et al.  Global patterns of 16S rRNA diversity at a depth of millions of sequences per sample , 2010, Proceedings of the National Academy of Sciences.

[27]  William A. Walters,et al.  QIIME allows analysis of high-throughput community sequencing data , 2010, Nature Methods.

[28]  A. Burt,et al.  Elevated endotoxin levels in non-alcoholic fatty liver disease , 2010, Journal of Inflammation.

[29]  N. Cerf-Bensussan,et al.  Multiple facets of intestinal permeability and epithelial handling of dietary antigens , 2010, Mucosal Immunology.

[30]  P. Bork,et al.  A human gut microbial gene catalogue established by metagenomic sequencing , 2010, Nature.

[31]  Jerrold R. Turner,et al.  Intestinal mucosal barrier function in health and disease , 2009, Nature Reviews Immunology.

[32]  T. Sugiyama,et al.  Lipopolysaccharide triggered TNF-alpha-induced hepatocyte apoptosis in a murine non-alcoholic steatohepatitis model. , 2009, Journal of hepatology.

[33]  G. La Torre,et al.  Increased intestinal permeability and tight junction alterations in nonalcoholic fatty liver disease , 2009, Hepatology.

[34]  B. Neuschwander‐Tetri,et al.  Severe NAFLD with hepatic necroinflammatory changes in mice fed trans fats and a high-fructose corn syrup equivalent. , 2008, American journal of physiology. Gastrointestinal and liver physiology.

[35]  B. Roe,et al.  A core gut microbiome in obese and lean twins , 2008, Nature.

[36]  E. Dejana,et al.  Unique role of junctional adhesion molecule-a in maintaining mucosal homeostasis in inflammatory bowel disease. , 2008, Gastroenterology.

[37]  B. Jaber,et al.  Endotoxin-Binding Affinity of Sevelamer Hydrochloride , 2008, American Journal of Nephrology.

[38]  E. Severson,et al.  JAM-A regulates permeability and inflammation in the intestine in vivo , 2007, The Journal of experimental medicine.

[39]  J. Ferrières,et al.  Metabolic Endotoxemia Initiates Obesity and Insulin Resistance , 2007, Diabetes.

[40]  E. Mardis,et al.  An obesity-associated gut microbiome with increased capacity for energy harvest , 2006, Nature.

[41]  U. Gophna,et al.  Differences between Tissue-Associated Intestinal Microfloras of Patients with Crohn's Disease and Ulcerative Colitis , 2006, Journal of Clinical Microbiology.

[42]  Rob Knight,et al.  UniFrac – An online tool for comparing microbial community diversity in a phylogenetic context , 2006, BMC Bioinformatics.

[43]  F. Bäckhed,et al.  Host-Bacterial Mutualism in the Human Intestine , 2005, Science.

[44]  Thomas N. Sato,et al.  Increased DC trafficking to lymph nodes and contact hypersensitivity in junctional adhesion molecule-A-deficient mice. , 2004, The Journal of clinical investigation.

[45]  L. Hooper,et al.  Bacterial contributions to mammalian gut development. , 2004, Trends in microbiology.

[46]  H. Liapis,et al.  Sevelamer hydrochloride attenuates kidney and cardiovascular calcifications in long-term experimental uremia. , 2003, Kidney international.

[47]  E. Wherry,et al.  Viral Persistence Alters CD8 T-Cell Immunodominance and Tissue Distribution and Results in Distinct Stages of Functional Impairment , 2003, Journal of Virology.

[48]  M. Gassull,et al.  Oral bile acids reduce bacterial overgrowth, bacterial translocation, and endotoxemia in cirrhotic rats , 2003, Hepatology.

[49]  I. Roberts-Thomson,et al.  The role of small intestinal bacterial overgrowth, intestinal permeability, endotoxaemia, and tumour necrosis factor α in the pathogenesis of non-alcoholic steatohepatitis , 2001, Gut.

[50]  A. Meyer,et al.  THE IMPACT OF FEMUR FRACTURE WITH ASSOCIATED SOFT TISSUE INJURY ON IMMUNE FUNCTION AND INTESTINAL PERMEABILITY , 1996, Shock.

[51]  D. Sorescu,et al.  Glp-1 analog, liraglutide, ameliorates hepatic steatosis and cardiac hypertrophy in C57BL/6J mice fed a Western diet. , 2012, American journal of physiology. Gastrointestinal and liver physiology.

[52]  Joel Z Stengel,et al.  Prevalence of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis among a largely middle-aged population utilizing ultrasound and liver biopsy: a prospective study. , 2011, Gastroenterology.

[53]  S. Friedman Hepatic stellate cells: protean, multifunctional, and enigmatic cells of the liver. , 2008, Physiological reviews.

[54]  C. Knauf,et al.  Comment on: Cani et al. (2007) Metabolic Endotoxemia Initiates Obesity and Insulin Resistance: Diabetes , 2007 .

[55]  G. Farrell,et al.  Etiopathogenesis of Nonalcoholic Steatohepatitis , 2001, Seminars in liver disease.